New Acylcarnitine Ratio as a Reliable Indicator of Long-Chain 3-Hydroxyacyl-CoA Dehydrogenase Deficiency

Long-chain 3-hydroxyacyl-CoA dehydrogenase (LCHAD) and mitochondrial trifunctional protein (MTP) deficiencies are rare fatal disorders of fatty acid β-oxidation with no apparent genotype–phenotype correlation. The measurement of acylcarnitines by MS/MS is a current diagnostic workup in these disorde...

Full description

Bibliographic Details
Main Authors: Galina V. Baydakova, Polina G. Tsygankova, Natalia L. Pechatnikova, Olga A. Bazhanova, Yana D. Nazarenko, Ekaterina Y. Zakharova
Format: Article
Language:English
Published: MDPI AG 2023-08-01
Series:International Journal of Neonatal Screening
Subjects:
Online Access:https://www.mdpi.com/2409-515X/9/3/48
_version_ 1797579571069976576
author Galina V. Baydakova
Polina G. Tsygankova
Natalia L. Pechatnikova
Olga A. Bazhanova
Yana D. Nazarenko
Ekaterina Y. Zakharova
author_facet Galina V. Baydakova
Polina G. Tsygankova
Natalia L. Pechatnikova
Olga A. Bazhanova
Yana D. Nazarenko
Ekaterina Y. Zakharova
author_sort Galina V. Baydakova
collection DOAJ
description Long-chain 3-hydroxyacyl-CoA dehydrogenase (LCHAD) and mitochondrial trifunctional protein (MTP) deficiencies are rare fatal disorders of fatty acid β-oxidation with no apparent genotype–phenotype correlation. The measurement of acylcarnitines by MS/MS is a current diagnostic workup in these disorders. Nevertheless, false-positive and false-negative results have been reported, highlighting a necessity for more sensitive and specific biomarkers. This study included 54 patients with LCHAD/MTP deficiency that has been confirmed by biochemical and molecular methods. The analysis of acylcarnitines in dried blood spots was performed using ESI-MS/MS. The established “HADHA ratio” = (C16OH + C18OH + C18:1OH)/C0 was significantly elevated in all 54 affected individuals in comparison to the control group. Apart from 54 LCHAD deficiency patients, the “HADHA ratio” was calculated in 19 patients with very-long-chain acyl-CoA dehydrogenase (VLCAD) deficiency. As VLCAD-deficient patients did not show increased “HADHA ratio”, the results emphasized the high specificity of this new ratio. Therefore, the “HADHA ratio” was shown to be instrumental in improving the overall performance of MS/MS-based analysis of acylcarnitine levels in the diagnostics of LCHAD/MTP deficiencies. The ratio was demonstrated to increase the sensitivity and specificity of this method and reduce the chances of false-negative results.
first_indexed 2024-03-10T22:39:01Z
format Article
id doaj.art-3da0836b0bf74305b23b5110fcae18d9
institution Directory Open Access Journal
issn 2409-515X
language English
last_indexed 2024-03-10T22:39:01Z
publishDate 2023-08-01
publisher MDPI AG
record_format Article
series International Journal of Neonatal Screening
spelling doaj.art-3da0836b0bf74305b23b5110fcae18d92023-11-19T11:12:29ZengMDPI AGInternational Journal of Neonatal Screening2409-515X2023-08-01934810.3390/ijns9030048New Acylcarnitine Ratio as a Reliable Indicator of Long-Chain 3-Hydroxyacyl-CoA Dehydrogenase DeficiencyGalina V. Baydakova0Polina G. Tsygankova1Natalia L. Pechatnikova2Olga A. Bazhanova3Yana D. Nazarenko4Ekaterina Y. Zakharova5Research Centre for Medical Genetics, Moskvorechye Str., 1, 115522 Moscow, RussiaResearch Centre for Medical Genetics, Moskvorechye Str., 1, 115522 Moscow, RussiaMorozov Children’s City Clinical Hospital, 4th Dobryninsky Lane, 1/9, 119049 Moscow, RussiaResearch Centre for Medical Genetics, Moskvorechye Str., 1, 115522 Moscow, RussiaResearch Centre for Medical Genetics, Moskvorechye Str., 1, 115522 Moscow, RussiaResearch Centre for Medical Genetics, Moskvorechye Str., 1, 115522 Moscow, RussiaLong-chain 3-hydroxyacyl-CoA dehydrogenase (LCHAD) and mitochondrial trifunctional protein (MTP) deficiencies are rare fatal disorders of fatty acid β-oxidation with no apparent genotype–phenotype correlation. The measurement of acylcarnitines by MS/MS is a current diagnostic workup in these disorders. Nevertheless, false-positive and false-negative results have been reported, highlighting a necessity for more sensitive and specific biomarkers. This study included 54 patients with LCHAD/MTP deficiency that has been confirmed by biochemical and molecular methods. The analysis of acylcarnitines in dried blood spots was performed using ESI-MS/MS. The established “HADHA ratio” = (C16OH + C18OH + C18:1OH)/C0 was significantly elevated in all 54 affected individuals in comparison to the control group. Apart from 54 LCHAD deficiency patients, the “HADHA ratio” was calculated in 19 patients with very-long-chain acyl-CoA dehydrogenase (VLCAD) deficiency. As VLCAD-deficient patients did not show increased “HADHA ratio”, the results emphasized the high specificity of this new ratio. Therefore, the “HADHA ratio” was shown to be instrumental in improving the overall performance of MS/MS-based analysis of acylcarnitine levels in the diagnostics of LCHAD/MTP deficiencies. The ratio was demonstrated to increase the sensitivity and specificity of this method and reduce the chances of false-negative results.https://www.mdpi.com/2409-515X/9/3/48biochemical markerinherited metabolic diseasesacylcarnitineslong-chain 3-hydroxyacyl-CoA dehydrogenase deficiency<i>HADHA</i>
spellingShingle Galina V. Baydakova
Polina G. Tsygankova
Natalia L. Pechatnikova
Olga A. Bazhanova
Yana D. Nazarenko
Ekaterina Y. Zakharova
New Acylcarnitine Ratio as a Reliable Indicator of Long-Chain 3-Hydroxyacyl-CoA Dehydrogenase Deficiency
International Journal of Neonatal Screening
biochemical marker
inherited metabolic diseases
acylcarnitines
long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency
<i>HADHA</i>
title New Acylcarnitine Ratio as a Reliable Indicator of Long-Chain 3-Hydroxyacyl-CoA Dehydrogenase Deficiency
title_full New Acylcarnitine Ratio as a Reliable Indicator of Long-Chain 3-Hydroxyacyl-CoA Dehydrogenase Deficiency
title_fullStr New Acylcarnitine Ratio as a Reliable Indicator of Long-Chain 3-Hydroxyacyl-CoA Dehydrogenase Deficiency
title_full_unstemmed New Acylcarnitine Ratio as a Reliable Indicator of Long-Chain 3-Hydroxyacyl-CoA Dehydrogenase Deficiency
title_short New Acylcarnitine Ratio as a Reliable Indicator of Long-Chain 3-Hydroxyacyl-CoA Dehydrogenase Deficiency
title_sort new acylcarnitine ratio as a reliable indicator of long chain 3 hydroxyacyl coa dehydrogenase deficiency
topic biochemical marker
inherited metabolic diseases
acylcarnitines
long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency
<i>HADHA</i>
url https://www.mdpi.com/2409-515X/9/3/48
work_keys_str_mv AT galinavbaydakova newacylcarnitineratioasareliableindicatoroflongchain3hydroxyacylcoadehydrogenasedeficiency
AT polinagtsygankova newacylcarnitineratioasareliableindicatoroflongchain3hydroxyacylcoadehydrogenasedeficiency
AT natalialpechatnikova newacylcarnitineratioasareliableindicatoroflongchain3hydroxyacylcoadehydrogenasedeficiency
AT olgaabazhanova newacylcarnitineratioasareliableindicatoroflongchain3hydroxyacylcoadehydrogenasedeficiency
AT yanadnazarenko newacylcarnitineratioasareliableindicatoroflongchain3hydroxyacylcoadehydrogenasedeficiency
AT ekaterinayzakharova newacylcarnitineratioasareliableindicatoroflongchain3hydroxyacylcoadehydrogenasedeficiency